- Home
- GRABW vs LYEL Comparison
GRABW vs LYEL Comparison
Compare GRABW & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRABW
- LYEL
- Stock Information
- Founded
- GRABW N/A
- LYEL 2018
- Country
- GRABW Singapore
- LYEL United States
- Employees
- GRABW 10604
- LYEL N/A
- Industry
- GRABW Business Services
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- GRABW Consumer Discretionary
- LYEL Health Care
- Exchange
- GRABW Nasdaq
- LYEL Nasdaq
- Market Cap
- GRABW N/A
- LYEL 263.9M
- IPO Year
- GRABW N/A
- LYEL 2021
- Fundamental
- Price
- GRABW $0.43
- LYEL $0.65
- Analyst Decision
- GRABW
- LYEL Sell
- Analyst Count
- GRABW 0
- LYEL 2
- Target Price
- GRABW N/A
- LYEL $1.00
- AVG Volume (30 Days)
- GRABW N/A
- LYEL 1.3M
- Earning Date
- GRABW N/A
- LYEL 02-26-2025
- Dividend Yield
- GRABW N/A
- LYEL N/A
- EPS Growth
- GRABW N/A
- LYEL N/A
- EPS
- GRABW N/A
- LYEL N/A
- Revenue
- GRABW N/A
- LYEL $63,000.00
- Revenue This Year
- GRABW N/A
- LYEL N/A
- Revenue Next Year
- GRABW N/A
- LYEL N/A
- P/E Ratio
- GRABW N/A
- LYEL N/A
- Revenue Growth
- GRABW N/A
- LYEL N/A
- 52 Week Low
- GRABW N/A
- LYEL $0.58
- 52 Week High
- GRABW N/A
- LYEL $3.26
- Technical
- Relative Strength Index (RSI)
- GRABW 47.11
- LYEL 34.74
- Support Level
- GRABW $0.39
- LYEL $0.60
- Resistance Level
- GRABW $0.49
- LYEL $0.71
- Average True Range (ATR)
- GRABW 0.05
- LYEL 0.06
- MACD
- GRABW -0.01
- LYEL 0.01
- Stochastic Oscillator
- GRABW 26.67
- LYEL 23.51
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.